Naloxone Hydrochloride Spray
Product Images NDC 80425-0409

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 80425-0409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Naloxone HCl Nasal Spray #2 (Naloxone HCl Nasal Spray 80425 0409 01)

Naloxone HCl Nasal Spray #2 (Naloxone HCl Nasal Spray 80425 0409 01)
Label for NALOXONE HYDROCHLORIDE 4 mg nasal spray by Advanced Rx of Tennessee, LLC. The label compares the product to Narcan and includes NDC numbers and lot/expiration dates. It also features storage instructions and a barcode, indicating the product is a nasal spray for opioid overdose reversal.*
FDA Label Image

Step 1 (Image 01)

Step 1 (Image 01)
An instructional illustration showing a person kneeling beside another person lying face up, with the label text '1 CHECK WAKE UP'. This diagram likely depicts the first step of an emergency response, demonstrating how to check if someone is responsive.*
FDA Label Image

Step 2 (Image 02)

Step 2 (Image 02)
An instructional diagram showing a person holding a nasal spray device and administering the spray into one nostril. The image is labeled with the number '2' and the word 'GIVE,' indicating the second step in the usage process.*
FDA Label Image

Step 3 (Image 03)

Step 3 (Image 03)
The image is an instructional illustration depicting a hand holding a phone with the screen showing "911 Emergency" and a finger about to press the call button, alongside an emergency vehicle icon. It conveys the action of calling emergency services in a crisis situation.*
FDA Label Image

Step 4 (Image 04)

Step 4 (Image 04)
An instructional diagram showing the recommended 2 to 3 minutes observation period after administering a nasal spray. It includes a stylized image of a hand holding a nasal spray towards a person's nose with an arrow indicating time and action to watch or give during this period.*
FDA Label Image

Step 5 (Image 05)

Step 5 (Image 05)
An illustration showing three human figures and an ambulance. One person is standing, another is seated, and a third is running toward the ambulance. The image is part of an instructional or safety sequence with the label '5 STAY.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.